Get the Stockscreener App
296.30
0.71%
-2.13
After Hours:
296.00
-0.30
-0.10%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Amgen Inc stock is traded at $296.30, with a volume of 2.75M.
It is down -0.71% in the last 24 hours and down -0.53% over the past month.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
See More
Previous Close:
$298.43
Open:
$298.43
24h Volume:
2.75M
Relative Volume:
1.20
Market Cap:
$159.52B
Revenue:
$34.76B
Net Income/Loss:
$6.62B
P/E Ratio:
24.24
EPS:
12.223
Net Cash Flow:
$10.61B
1W Performance:
+1.77%
1M Performance:
-0.53%
6M Performance:
+5.36%
1Y Performance:
-7.18%
1-Day Range:
$292.12
$301.00
1-Week Range:
$288.00
$301.00
52-Week Range:
$253.30
$335.88
Amgen Inc Stock (AMGN) Company Profile
Name
Amgen Inc
Sector
Industry
Phone
(805)447-1000
Address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
296.30 | 160.66B | 34.76B | 6.62B | 10.61B | 12.22 |
|
LLY
Lilly Eli Co
|
896.53 | 772.28B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
186.26 | 455.04B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
211.96 | 385.18B | 59.64B | 2.37B | 18.24B | 1.331 |
|
NVS
Novartis Ag Adr
|
123.86 | 237.53B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
82.49 | 214.76B | 63.99B | 19.05B | 14.72B | 7.5596 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Resumed | Raymond James | Mkt Perform |
| May-20-25 | Resumed | Guggenheim | Neutral |
| Apr-22-25 | Resumed | Cantor Fitzgerald | Neutral |
| Dec-10-24 | Resumed | BofA Securities | Underperform |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-14-24 | Initiated | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Outperform |
| Oct-14-24 | Downgrade | Truist | Buy → Hold |
| Sep-27-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-03-24 | Upgrade | Barclays | Underweight → Equal Weight |
| May-03-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Mar-28-24 | Resumed | Raymond James | Mkt Perform |
| Feb-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-21-23 | Upgrade | Daiwa Securities | Neutral → Buy |
| Dec-19-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Nov-02-23 | Upgrade | Truist | Hold → Buy |
| Oct-20-23 | Resumed | JP Morgan | Neutral |
| Oct-17-23 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-11-23 | Resumed | BofA Securities | Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Apr-24-23 | Reiterated | Oppenheimer | Outperform |
| Mar-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-13-23 | Reiterated | Truist | Buy |
| Nov-18-22 | Initiated | Credit Suisse | Underperform |
| Oct-31-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-11-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Feb-09-22 | Reiterated | Barclays | Equal Weight |
| Feb-09-22 | Reiterated | Jefferies | Buy |
| Feb-09-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Feb-09-22 | Reiterated | Oppenheimer | Outperform |
| Feb-09-22 | Reiterated | Wells Fargo | Equal Weight |
| Jan-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-21 | Resumed | Wells Fargo | Equal Weight |
| Dec-06-21 | Initiated | Goldman | Buy |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Sep-23-21 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-29-20 | Initiated | Daiwa Securities | Buy |
| Oct-28-20 | Initiated | UBS | Neutral |
| Oct-26-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-12-20 | Upgrade | Truist | Hold → Buy |
| Oct-09-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Oct-09-20 | Downgrade | Truist | Buy → Hold |
| Oct-08-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-15-20 | Resumed | Guggenheim | Neutral |
| Mar-31-20 | Initiated | Wolfe Research | Peer Perform |
| Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-05-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Jan-31-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Jan-21-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-24-19 | Initiated | Raymond James | Mkt Perform |
| Dec-17-19 | Resumed | Morgan Stanley | Overweight |
| Nov-12-19 | Initiated | SunTrust | Buy |
| Nov-05-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-19-19 | Downgrade | Mizuho | Buy → Neutral |
| May-23-19 | Upgrade | Citigroup | Neutral → Buy |
View All
Amgen Inc Stock (AMGN) Latest News
Amgen sues Colorado over state’s first-in-the-nation price ceiling on arthritis drug Enbrel - The Daily Gazette
AMD, Arista, Amgen, and more set to report earnings Tuesday - Investing.com
How Amgen Inc. stock compares to growth peersPortfolio Risk Summary & Technical Pattern Alert System - newser.com
Institutional scanner results for Amgen Inc.Portfolio Growth Summary & Weekly Top Gainers Trade List - newser.com
Amgen Defends Patent For Thyroid Disease Drug At EPO - Law360
Why analysts maintain buy rating on Amgen Inc. (AMG0) stockTrade Volume Report & Technical Entry and Exit Tips - newser.com
US Cancer Immunotherapy Forecast and Company Analysis Report 2025-2033 Featuring Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Pfizer, Novartis, Johnson & Johnson, Eli Lily Co, Seattle GeneticsResearchAndMarkets.com - FinancialContent
Aurdan Capital Management LLC Sells 4,937 Shares of Amgen Inc. $AMGN - MarketBeat
Verity Asset Management Inc. Sells 3,971 Shares of Amgen Inc. $AMGN - MarketBeat
Hunter Associates Investment Management LLC Sells 2,190 Shares of Amgen Inc. $AMGN - MarketBeat
Bank of Montreal Can Cuts Stake in Amgen Inc. $AMGN - MarketBeat
SS&H Financial Advisors Inc. Cuts Position in Amgen Inc. $AMGN - MarketBeat
Burney Co. Acquires 1,157 Shares of Amgen Inc. $AMGN - MarketBeat
Telos Capital Management Inc. Raises Position in Amgen Inc. $AMGN - MarketBeat
How dovish Fed policy supports Amgen Inc. (AMG) stockStop Loss & Daily Stock Trend Reports - newser.com
Wakefield Asset Management LLLP Acquires Shares of 1,974 Amgen Inc. $AMGN - MarketBeat
Plato Investment Management Ltd Increases Position in Amgen Inc. $AMGN - MarketBeat
(AMGN) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Tredje AP fonden Decreases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Lifeworks Advisors LLC Trims Stock Holdings in Amgen Inc. $AMGN - MarketBeat
How supply shortages influence Amgen Inc. (AMG) stockWeekly Profit Report & Reliable Volume Spike Trade Alerts - newser.com
Will breakout in Amgen Inc. lead to full recoveryMarket Performance Recap & Fast Exit and Entry Strategy Plans - newser.com
What MACD trends signal for Amgen Inc. (AMG0) stockWeekly Trend Summary & Community Trade Idea Sharing Platform - newser.com
Is Amgen Inc. stock a contrarian buyDay Trade & Verified Entry Point Detection - newser.com
Why global investors buy Amgen Inc. (AMG) stockJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - newser.com
What Fibonacci levels say about Amgen Inc. reboundJuly 2025 Weekly Recap & High Accuracy Investment Signals - newser.com
Amgen Earnings: What To Look For From AMGN - FinancialContent
What is the fair value estimate for Amgen Inc. (AMG) stock in 2025Weekly Loss Report & Consistent Return Investment Signals - newser.com
Why global investors buy Amgen Inc. (AMG0) stockEarnings Recap Report & Accurate Technical Buy Alerts - newser.com
Will Amgen Inc. (AMG0) stock recover faster than industryWeekly Risk Report & Capital Efficiency Focused Strategies - newser.com
What dividend safety score for Amgen Inc. stockPortfolio Performance Report & Verified Chart Pattern Signals - newser.com
Longbow Finance SA Takes $7.07 Million Position in Amgen Inc. $AMGN - MarketBeat
Syverson Strege & Co Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Maintains Quarterly Dividend of $2.38 Per Share - GuruFocus
AlphaStar Capital Management LLC Acquires New Shares in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Integrity Alliance LLC. - MarketBeat
Will Amgen Inc. (AMG0) stock outperform energy sector in 2025Earnings Summary Report & Breakout Confirmation Alerts - newser.com
Does Amgen Inc. fit your quant trading modelTreasury Yields & AI Powered Market Entry Ideas - newser.com
Amgen Inc. $AMGN Shares Acquired by Mesirow Financial Investment Management Inc. - MarketBeat
Amgen Inc. $AMGN Shares Sold by Spire Wealth Management - MarketBeat
Using flow based indicators on Amgen Inc.2025 Performance Recap & Reliable Intraday Trade Plans - newser.com
Amgen Inc. (NASDAQ:AMGN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases - Yahoo Finance
How Amgen’s (AMGN) Dividend and Tezspire Approval Could Shape Investor Expectations for 2025 - simplywall.st
Amgen, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Why Amgen Inc. (AMG) stock could be top winner2025 Buyback Activity & Free Safe Capital Growth Stock Tips - newser.com
Bridgewealth Advisory Group LLC Buys New Shares in Amgen Inc. $AMGN - MarketBeat
Fisher Funds Management LTD Sells 3,315 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Pinnacle Associates Ltd. - MarketBeat
Simon Quick Advisors LLC Purchases 1,051 Shares of Amgen Inc. $AMGN - MarketBeat
Impact Partnership Wealth LLC Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Amgen Inc Stock (AMGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
1.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):